Catapult Venture Managers Limited
Catapult Venture Managers (Catapult Ventures) is an independent venture capital fund manager that has been investing in UK businesses since 2002.
We are one of the most active seed and early stage life science investors in the UK managing the GM & Cheshire Life Sciences Fund that has invested in forty life science businesses in the last five years. Since 2015* Catapult has recorded 14 profitable exits, including many in the life science sector, such as Accutronics (9.1x), Lumora (4.7x), Oxford Cryosystems (5.2x), Monica Healthcare (3.6x), Panthera Biopartners (3.3x) and FDAS (2x) (*as at 31st December 2022). Catapult Ventures is not currently investing in new companies, but we continue to invest in our portfolio companies and help to build value and growth.
Catapult Ventures is all about value creation through long term relationships – both with our portfolio companies and those who have invested in the funds we manage. We have a passion for business and enjoy supporting ambitious entrepreneurs and management teams who share this enthusiasm.
Catapult Ventures is a trading name of Catapult Ultimate Holdings Ltd, which is the ultimate holding company of Catapult Venture Managers Ltd, which is authorised and regulated by the Financial Conduct Authority (FCA Registration No. 191949).